Why might amylin be combined with GLP-1 therapy
Oral administration results in rapid degradation by gastric acid and hepatic first-pass metabolism, rendering the compounds inactive before reaching systemic circulation
Human research demonstrated that methylcobalamin supplementation in patients with inadequate B12 levels improved CD4/CD8 ratio and NK cell activity, and augmented CD3-CD16+ cells, suggesting an important role in cellular immunity.[14] In other research, among homologues studied, methylcobalamin was shown to have the strongest antibody production enhancement on an in vitro system.*[15]
Yes, but people with absorption issues (due to age, diet, or health conditions) may not get sufficient B12 from pills alone
Combining them is meant to recruit the amylin pathway on top of the GLP-1 pathway, and the two were formally co-administered and tested together as CagriSema. [4] For the amylin side of that equation, our references on how cagrilintide affects gastric emptying and post-prandial metabolism and how cagrilintide influences brain satiety circuits go deeper into the mechanism
